DYNAMICS OF RESPONSE AND IMPACT OF SOKAL SCORE IN 3 MONTHS MOLECULAR 'WARNING' CML PATIENTS. A RETROSPECTIVE STUDY OF GRUPPO TRIVENETO LMC.

EHA Library, gianni binotto, 99876

AUTOMATED IMAGE ANALYSIS REVEALED A HIGH VARIABILITY OF CD30+ HRS CELLS DENSITY IN CLASSICAL NODULAR SCLEROSIS HODGKIN LYMPHOMA

EHA Library, Eva Kriegová, 99877

HODGKIN LYMPHOMA PATIENTS WITH HIGH NUMBER OF MACROPHAGES IN TUMOR TISSUE - RISK PROFILE AND TREATMENT OUTCOME

EHA Library, Bosko Andjelic, 99878

IMATINIB TREATMENT DURATION EFFECT ON ESTIMATED GLOMERULAR FILTRATION RATE IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Lenka Ruzickova, 99879

FLUDARABINE TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA-ASSOCIATED NEUROPATHY – 20 YEARS EXPERIENCE OF A SINGLE CENTER

EHA Library, Sinziana Radesi - Sarghi, 99880

HYPOGAMMAGLOBULINEMIA AT LONG-TERM AFTER RITUXIMAB/CHEMOTHERAPY TREATMENT FOR LYMPHOMA, AND USE OF INTRAVENOUS IMMUNOGLOBULINS FOR RECURRENT INFECTIONS.

EHA Library, Mariana Ferraro, 99881

EFFICACY AND SAFETY OF DASATINIB VS. IMATINIB IN LATIN AMERICAN SUBPOPULATION FROM THE DASISION TRIAL IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE (CP)

EHA Library, Alicia Enrico, 99882

THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPAŞA CML COHORT

EHA Library, A. Emre Eskazan, 99883

CIRCULATING ADAMTS-13 IS REDUCED IN PATIENTS WITH WALDENSTROM'S MACROGLOBULINEMIA AND IS ASSOCIATED WITH INCREASED IGM LEVELS AND DISEASE FEATURES BUT NOT WITH THE LEVELS OF VON WILLEBRAND FACTOR

EHA Library, Efstathios Kastritis, 99884

ANALYSIS OF THE RELATIONSHIP BETWEEN DOSE AND BCR-ABL HALVING TIME IN CP-CML PATIENTS TREATED WITH PONATINIB OR IMATINIB

EHA Library, Justin Pritchard, 99885

CAR MEDIATES DIFFERENTIATION AND MIGRATION OF ERYTHROPOIETIC PROGENITOR CELLS AND IS SPECIFICALLY DOWN-REGULATED IN MDS

EHA Library, Karin Bauer, 99886

RUNX1 MUTATION AND LOW RUNX1 TRANSACTIVATING ACTIVITY PREDICT HIGHER RISK OF AML TRNASFORMATION AND INFERIOR LEUKEMIA-FREE SURVIVAL IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Ming-Chung Kuo, 99887

ABNORMAL MONOCYTE POPULATIONS IN THE PERIPHERAL BLOOD OF PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Maria Velegraki, 99888

GLUTATHIONE S-TRANSFERASE P1 (GSTP1) PROMOTER HYPERMETHYLATION IN MDS/AML: ASSOCIATION WITH SPECIFIC CHROMOSOME ABBERATIONS

EHA Library, Constantina Sambani, 99889

RITUXIMAB WITH OR WITHOUT CHLORAMBUCIL FOR THE TREATMENT OF EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA: RESULTS OF A MONOCENTRIC STUDY.

EHA Library, Luigi Rigacci, 99890

IN VITRO CULTURE OF BM CELLS OF MDS PATIENTS AND CYTC POLYMORPHISMS CAN PREDICT THE “IN VIVO” HEMATOLOGICAL RESPONSE OBSERVED DURING IRON CHELATION THERAPY WITH DEFERASIROX

EHA Library, Daniela Cilloni, 99891

INDUCTION PHASE INFECTIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND IMPACT OF STEROID DOSE ON THE INCIDENCE OF INFECTIONS: A RANDOMIZED CONTROLLED STUDY

EHA Library, Turan Bayhan, 99892

AUTOPHAGY LEVEL WAS ABNORMAL IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Huaquan Wang, 99893

VIRAL RESPIRATORY TRACT INFECTIONS IN CHILDREN WITH MALIGNANCY: ISTANBUL PERSPECTIVE

EHA Library, ZEYNEP KARAKAS, 99894

PROGNOSTIC AND PREDICTIVE VALUE OF IPSS-R IN ASSESSING OVERALL SURVIVAL (OS) IN A PHASE III STUDY OF RIGOSERTIB IN SECOND-LINE HIGHER-RISK (HR) MDS PATIENTS

EHA Library, Lewis Silverman, 99895

INCREASED IMMUNE ACTIVATION AND IMPAIRED CELL SUPPRESSION ON MYELODYSPLASTICS SYNDROMES PROGRESSION

EHA Library, Aline Perazzio, 99896

IMMUNE EXACERBATION ON MYELODYSPLASTICS SYNDROMES

EHA Library, Aline Perazzio, 99897

BIOSIMILAR FILGRASTIM IN PATIENTS UNDERGOING NEUTROPENIA-INDUCING CHEMOTHERAPY: OVERALL RESULTS FROM THE NEXT OBSERVATIONAL STUDY

EHA Library, Frederic Maloisel, 99898

ORGANIZING PNEUMONIA IN HEMATO-ONCOLOGY PATIENTS: A SOMEWHAT DISREGARDED DIFFERENTIAL DIAGNOSIS

EHA Library, Gil Brás, 99899

INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE: REPORT FROM A SINGLE CENTER

EHA Library, Angela Maria Quinto, 99900

RABBIT ANTITHYMOCYTE GLOBULIN AT > 3,5 MG/KG/DAY/X 5 DAYS FOR TREATMENT OFACQUIRED APLASTIC ANEMIA

EHA Library, Juan Carlos Vallejo Llamas, 99901

ANIDULAFUNGIN THERAPY FOR HIGH RISK OF INVASIVE FUNGAL INFECTION HEMATOLOGIC PATIENTS: ITS ROLE IN REAL-LIFE SINGLE CENTER EXPERIENCE.

EHA Library, Sara Lozano, 99902

LOW-RISK MYELODYSPLASTIC PATIENTS SUPPORTED WITH ERYTHROPOIETIN PLUS LIPOSOMIAL IRON SHOWS A REDUCED NUMBER OF FEBRILE EPISODES THAN PATIENTS WITH INTRAVENOUS IRON SUPPORT.

EHA Library, GIULIO GIORDANO, 99903

RISK FACTORS FOR FEBRILE NEUTROPENIA AND BLOODSTREAM INFECTIONS IN RECIPIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTS

EHA Library, Igor Stoma, 99904

ANALYSIS OF 75 CASES OF ACUTE LEUKEMIA WITH INVASIVE FUNGAL DISEASE

EHA Library, Ye-Hui Tan, 99905

LOOKING FOR HYPOXIA FINGERPRINT IN MALIGNANT PLASMA CELL APPLIED TO NORMOXIC ENVIRONMENT.

EHA Library, Kinga Kocemba, 99906

IN HOUSE NEXT GENERATION SEQUENCING METHOD OF INMUNOGLOBULIN GENES FOR MINIMAL RESIDUAL DISSEASE QUANTIFICATION IN MULTIPLE MYELOMA

EHA Library, Joaquin Martinez-Lopez, 99907

NOCARDIA INFECTION IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Maria Stamouli, 99908

INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE

EHA Library, Sofia Ramos, 99909

VARIOUS PATTERNS OF HEPATITIS B VIRUS REACTIVATION IN B CELL LYMPHOMA

EHA Library, Aya Nakaya, 99910

PERSONAL HISTORY OF INFECTIONS ASSOCIATED WITH AN INCREASED RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) AND MULTIPLE MYELOMA: A POPULATION-BASED NESTED CASE-CONTROL STUDY

EHA Library, Charlene McShane, 99911

INFLUENCE OF ABC TRANSPORTERS’ GENETIC PROFILES IN THE DEVELOPMENT OF MONOCLONAL GAMMOPATHIES

EHA Library, Ana Bela Sarmento-Ribeiro, 99912

CIRCULATING MICRORNAS IN PLASMA OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Michaela Dostalova Merkerova, 99913

TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND AND DEATH RECEPTORS: RELEVANCE IN THE PATHOGENESIS OF MONOCLONAL GAMMOPATHIES

EHA Library, Catarina Geraldes, 99914

MUTATIONAL PROFILE IN MYELODYSPLASTIC SYNDROMES BY HIGH-DEPTH NEXT GENERATION SEQUENCING AND CLINICAL RELEVANCE

EHA Library, Maria Teresa Cedena, 99915

TS, MTHFR AND XRCC1 GENETIC VARIANTS AFFECT THE CLINICAL COURSE OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK

EHA Library, Federica Loscocco, 99916

SIRPB1: BIOMARKER OF RESPONSE TO 5-AZACITIDINE TREATMENT IN MDS AND AML PATIENTS

EHA Library, Viviana Guadagnuolo, 99917

RPS14 EXPRESSION IN MYELODYSPLASTIC SYNDROME WITHOUT 5Q DELETION

EHA Library, Keina Susana Quiroz Cervantes, 99918

IMMUNOGLOBULIN HEAVY/LIGHT CHAIN IMMUNOASSAYS FOR RESPONSE EVALUATION IN MULTIPLE MYELOMA: COMPARISON WITH IMMUNOFIXATION, SERUM FREE LIGHT CHAIN, AND MULTICOLOR FLOW- CYTOMETRY

EHA Library, Yasuhito Suehara, 99919

CLINICAL RELEVANCE OF IL-6 AND TNF-ALFA IN THE CHARACTERIZATION OF LEUKEMIC STEM CELLS IN MDS PATIENTS

EHA Library, Emília Cortesão, 99920

MOLECULAR PROFILE OF TRANSFORMED AND NON TRANSFORMED INDIAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Rekha Chaubey, 99921

MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS : EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE

EHA Library, Claudio Cerchione, 99922

IMPACT OF TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN ALPHA ON CARDIAC REMODELING IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: RESULTS FROM A PROSPECTIVE STUDY

EHA Library, Arboscello Eleonora, 99923

ACUTE MYELOID LEUKEMIA PROGRESSION IN ARGENTINEAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.

EHA Library, Alicia Enrico, 99924

PULMONARY INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RECEIVING AZACYTIDINE TREATMENT

EHA Library, Roberto Latagliata, 99925

HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY.

EHA Library, Jose María Bastida, 99926

EFFECTIVENESS OF AZACITIDINE COMPARED TO CONVENTIONAL CARE REGIMENS FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASIA IN THE REAL-WORLD: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

EHA Library, Avinash Dinmohamed, 99927

CLINICAL FEATURES, TREATMENT DECISIONS AND TREATMENT OUTCOMES OF PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) IN THE REAL-WORLD: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

EHA Library, Avinash Dinmohamed, 99928

A NEW PROGNOSTIC INDEX TO PREDICT SHORT-TERM PROGNOSIS IN MDS PATIENTS TREATED WITH AZACITIDINE; COMBINATION OF P53 EXPRESSION AND CYTOGENETICS

EHA Library, Satoshi Nishiwaki, 99929

DIAGNOSIS, PROGNOSTICATION AND TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) IN DAILY PRACTICE: RESULTS FROM THE DUTCH POPULATION-BASED PHAROS MDS REGISTRY

EHA Library, Avinash Dinmohamed, 99930

THE UTILITY OF GRANULOCYTE MATURATION PATTERNS ASSESSED BY FLOW CYTOMETRY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME

EHA Library, Sylvia Meisenberg, 99931

PATIENTS WITH THERAPY-RELATED CHRONIC MYELOMONOCYTIC LEUKEMIA (TR-CMML) HAVE SHORTER MEDIAN OVERALL SURVIVAL THAN DE NOVO CMML (DN-CMML): MAYO CLINIC EXPERIENCE

EHA Library, Salih Subari, 99932

STAT3 EXPRESSION IS ASSOCIATED WITH POOR SURVIVAL IN YOUNG PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Sung-Hoon Jung, 99933

HEPATITIS B REACTIVATION IN MULTIPLE MYELOMA PATIENTS WITH RESOLVED HEPATITIS B UNDERGOING CHEMOTHERAPY

EHA Library, Ji Yun Lee, 99934

HEMATOLOGIC MALIGNANCIES, MOSTLY MYELODYSPLASTIC SYNDROMES AMONG 1740 INFLAMMATORY BOWEL DISEASE PATIENTS: LONG TERM FOLLOW-UP DATA FROM A TERTIARY CENTER

EHA Library, Ayse Salihoglu, 99935

IMPACT OF AZACITIDINE ON RED BLOOD CELL ALLOINMUNIZATION IN MYELODISPLASTIC SYNDROME

EHA Library, Sebastián Ortiz Zuluaga, 99936

IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROME (MDS) IN ROUTINE CLINICAL SETTING: AN INTERIM ANALYSIS OF THE NON-INTERVENTIONAL STUDY EXSEPT

EHA Library, Forian Nolte, 99937

HEMOCHROMATOSIS GENE MUTATIONS MAY AFFECT THE SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Marko Lucijanic, 99938

P53 EXPRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AT DIAGNOSIS AND FOLLOWING TREATMENT WITH AZACITIDINE

EHA Library, Su Wai Maung, 99939

SUBGROUP ANALYSES OF A PHASE 3 STUDY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FAILING HMA TREATMENT: IDENTIFICATION OF A HOMOGENEOUS POPULATION WHO BENEFIT FROM RIGOSERTIB THERAPY

EHA Library, Gianluca Gaidano, 99940

THE ROLE OF INITIAL 18F-FDG PET/CT IN PATIENTS WITH POEMS SYNDROME

EHA Library, Hyunsoo Cho, 99941

TRIAL EFFICACY VS REAL WORLD EFFECTIVENESS IN FIRST LINE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Johan Liwing, 99942

LONG-LASTING HEMATOLOGIC RESPONSE TO AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: UPDATE OF CLINICAL RESULTS FROM A SINGLE INSTITUTION

EHA Library, Carlo Finelli, 99943

ELEVATED FACTOR VIII LEVELS CARRY A POOR OVERALL SURVIVAL IN NEWLY DIAGNOSED SYSTEMIC LIGHT CHAIN (AL) AMYLOIDOSIS PATIENTS.

EHA Library, Ashutosh Wechalekar, 99944

PROGNOSTIC IMPACT OF SERUM FREE LIGHT CHAIN (SFLC) EVALUATION IN PATIENTS WITH NEWLY DIAGNOSED SYMPTOMATIC MULTIPLE MYELOMA (MM) RECEIVING BORTEZOMIB (BTZ) -BASED REGIMENS

EHA Library, Paola Tacchetti, 99945

EVALUATION OF THE CHROMOSOMAL ABERRATION PATTERN IN IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS

EHA Library, Min-Young Lee, 99946

CIRCULATING BCMA BINDING TO ITS LIGAND BAFF PREVENTS NORMAL ANTIBODY PRODUCTION IN MULTIPLE MYELOMA PATIENTS

EHA Library, James Berenson, 99947

IMPACT OF SERUM ALPHA 1-ACID GLYCOPROTEIN (AAG), A POTENTIAL PATIENT SELECTION MARKER FOR FILANESIB, ON SURVIVAL AND RESPONSE TO CONVENTIONAL THERAPIES IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA (RMM)

EHA Library, Brian Tunquist, 99948

ANALYSIS OF RHOU AND RHOV EXPRESSION IN MULTIPLE MYELOMA REVEALS A POSSIBLE CORRELATION WITH BONE MARROW DEPENDENCE

EHA Library, Sara Nunes, 99949

A POPULATION BASED STUDY OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS IN LATVIA (2007-2009 YEARS)

EHA Library, Daiga Auzina, 99950

OUTCOME OF NEWLY DIAGNOSED SYMPTOMATIC MULTIPLE MYELOMA IN VERY ELDERLY PATIENTS (AGED 80 YEARS OR MORE)

EHA Library, Nicola Sgherza, 99951

INTENTION TO TREAT VS AGE OF DIAGNOSIS. ANALYSIS OF BENEFITIAL EFFECT OF NEW AGENTS IN THE TREATMENT OF NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Belen Ballina, 99952

THE AMPLIFICATION OF 1Q21 IS AN ADVERSE PROGNOSTIC FACTOR IN CHINESE PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Lijuan Chen, 99953

USE OF EARLY CHANGES IN GENE EXPRESSION OF PLASMA CELLS MAY PREDICT RESPONSE TO BORTEZOMIB IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Konstantinos Liapis, 99954

ANTI-GRP78 MONOCLONAL ANTIBODY PAT-SM6 IN REFRACTORY AND EXTRAMEDULLARY MULTIPLE MYELOMA: PRECLINICAL AND CLINICAL EVIDENCE FOR A COMBINATORIAL STRATEGY WITH NOVEL AGENTS

EHA Library, Leo Rasche, 99955

CLINICAL FEATURES, PROGNOSIS AND TREATMENT OUTCOME OF THE OF THE EXTRAOSSEUS PLASMA CELL NEOPLASIA: PLASMACYTOMA, MULTIPLE MYELOMA AND PRIMARY PLASMA CELL LEUKEMIA

EHA Library, Jelena Jelicic, 99956

DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING PARAMETERS CORRELATE WITH ANGIOPOIETIN-1/ANGIOPOIETIN-2 RATIO AND OTHER HIGH-RISK FEATURES IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Evangelos Terpos, 99957

SERUM LEVELS OF VON WILLEBRAND FACTOR (VWF) BUT NOT OF ADAMTS-13 PREDICT FOR EARLY DEATH IN PATIENTS WITH AL AMYLOIDOSIS, INDEPENDENTLY OF CARDIAC BIOMARKERS

EHA Library, Efstathios Kastritis, 99958

ANALYSIS OF OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS WITH 3 LINES OF THERAPY INCLUDING A PI AND AN IMID, OR DOUBLE REFRACTORY TO A PI AND AN IMID USING REAL WORLD DATA

EHA Library, Saad Usmani, 99959

FINDING MOLECULAR/EPIGENETIC SIGNATURES IN PHILADELPHIA NEGATIVE MPNS: A NOVEL TOOL FOR STRENGTHENING DISEASE STATUS CLASSIFICATION AND TAILORING PERSONALIZED DRUG STRATEGIES

EHA Library, Miguel Martin, 99960

SK053, AN INHIBITOR OF ENZYMES INVOLVED IN ALLOSTERIC DISULFIDE BONDS FORMATION, TARGETS EXPRESSION OF HISTONE GENES, SHOWS POTENT ANTI-LEUKEMIC EFFECTS AND INDUCES DIFFERENTIATION OF HUMAN AML CELLS

EHA Library, Justyna Chlebowska, 99961

ASSESSING TREATMENT RESPONSE IN MULTIPLE MYELOMA: IMPLICATIONS OF USING BONE MARROW PLASMA CELL CONTENT AS A MARKER OF DISEASE BURDEN

EHA Library, A. Kamel Abou Hussein, 99962

PATIENT EXPERIENCE WITH LIGHT CHAIN AMYLOIDOSIS: A SURVEY FROM THE AMYLOIDOSIS RESEARCH CONSORTIUM

EHA Library, Isabelle Lousada, 99963

TO TAKE HOME: HOW MUCH VALUE IS LOW BURDEN OF JAK2 V617F ALLELE MUTATION?

EHA Library, Laura Torres Miñana, 99964

CHRONIC INFLAMMATION BIOMARKERS IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Olivera Mitrovic, 99965

THE PRESENCE OF THE JAK2V617F POINT MUTATION AFFECTS OSTEOCLAST FUNCTION IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS.

EHA Library, Emmanouil Spanoudakis, 99966

PLATELET ANALYSIS INCREASES THE DETECTION OF MUTATIONS IN TRIPLE-NEGATIVE ESSENTIAL THROMBOCYTHEMIA PATIENTS

EHA Library, Anna Angona, 99967

BONE MARROW STROMA MEDIATED PROTECTION OF MPN CELLS FROM RUXOLITINIB- AND VORINOSTAT-INDUCED APOPTOSIS REQUIRES MAPK-JNK AND PI3K-AKT/PKB SIGNALING PATHWAY ACTIVATION

EHA Library, Antonio De Almeida, 99968

FREQUENCY AND ALLELE BURDEN OF CALR MUTATIONS IN CHINESE WITH ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS WITHOUT JAK2 V617F OR MPL MUTATIONS

EHA Library, Guo-Rui Ruan, 99969

SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED MULTIPLE MYELOMA

EHA Library, beatrice zannetti, 99970

THE ANTIPROLIFERATIVE EFFECT OF SIMVASTATIN IS ASSOCIATED WITH EPIGENETIC MECHANISMS IN NEOPLASTIC MAST CELLS

EHA Library, Heidrun Karlic, 99971

RE-TREATMENT VS CHANGE THERAPY IN FIRST RELAPSE: POST-HOC ANALYSIS OF 476 PATIENTS WITH MULTIPLE MYELOMA (MM) INCLUDED IN TWO PROSPECTIVE TRIALS

EHA Library, Massimo Offidani, 99972

AL AMYLOIDOSIS AND QUALITY OF LIFE OUTCOMES

EHA Library, Rahma Warsame, 99973

HEAVY/LIGHT CHAIN IMMUNOPARESIS AS A NOVEL MARKER OF POOR OUTCOMES IN SYSTEMIC AL AMYLOIDOSIS

EHA Library, Ashutosh Wechalekar, 99974

FIRST REPORT OF A PROSPECTIVE STUDY ON WHOLE-BODY DYNAMIC CONTRAST ENHANCED MRI IN NEWLY DIAGNOSED MYELOMA PATIENTS TREATED WITH UP-FRONT AUTOLOGOUS TRANSPLANTATION: DESCRIPTIVE STUDY AT BASELINE

EHA Library, Karim Belhadj, 99975